Full history for every metric is available with a Kvantra account

Stock profile

Ceapro Inc. (CRPOF)

Country: CanadaSector: HealthcareIndustry: BiotechnologyExchange: OTC

Delisted · last close 28 Jun 2024

Current price
4.42 USD-2.86%
Last close 28 Jun 2024
Benchmarks

Key financial summary

Financials in CAD
201820192020202120222023TTM
Total revenueCAD m1213151719109
Operating profitCAD m-6-8
Net profitCAD m-0-1234-5-6
EPS reportedCAD-0.06-0.08
Operating cashflow per shareCAD-0.05-0.05
Capex per shareCAD0.010.01
FCF per shareCAD-0.06-0.06
Free cash flowCAD m-5-7
Net debtCAD m-7-4
Book value equityCAD m2826
Book value per shareCAD0.360.33
Number of sharesm78.2778.29
DPS (TTM paid)CAD0.000.00

Financial summary

Financials in CAD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx26.000.73
P/S LTMx75.192.13
P/FCF LTMx-157.34-2.55
EV/EBITDA LTMx-187.42-2.51
EV/Sales LTMx74.511.64
Earnings Yield LTM%-0.65%-24.86%
FCF Yield%-0.64%-39.23%
Quality
ROE%-16.91%-15.66%
ROIC%-16.57%-16.57%
Operating margin%-64.93%-64.93%
Gross margin%36.99%36.99%
FCF/Sales%-47.79%-47.79%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-48.87%-44.86%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-2.05-3.46
Net Debt/EBITDAx1.721.72
EBIT/Net interestx-48.82-48.82
Net debt/market cap%-0.91%-22.92%
Net debt/Equityx-0.24-0.17
Gross debt/equityx0.080.08

Company overview

Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated on plant-derived compounds. Its commercial reach extends across the United States, Germany, China, Canada, and various other global markets. The company's operations are divided into two principal sectors. The first, its Active Ingredient Product Technology division, is centered on inventing and employing exclusive extraction methodologies. These are utilized for the manufacturing, refinement, and sale of potent substances like oat beta glucan and avenanthramides, extracted from oats and other sustainable botanical sources, serving both the healthcare and beauty industries. Conversely, the Cosmeceutical Industry segment concentrates on the creation and commercial release of anti-aging goods. These products, formulated from natural active components, are primarily distributed straight to consumers through the company's online portal and via a network of specialized natural product retailers. Established in 1997, Ceapro Inc.'s main corporate office is located in Edmonton, Canada.

WebsiteN/A
IndustryBiotechnology
CountryCanada
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 28 Jun 2024

Ceapro Inc. (CRPOF)

CRPOF · OTC · Healthcare
4.42 USD-2.86%
Benchmarks
Financialsin CAD
20222023TTM
About

Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated on plant-derived compounds. Its commercial reach extends across the United States, Germany, China, Canada, and various other global markets. The company's operations are divided into two principal sectors. The first, its Active Ingredient Product Technology division, is centered on inventing and employing exclusive extraction methodologies. These are utilized for the manufacturing, refinement, and sale of potent substances like oat beta glucan and avenanthramides, extracted from oats and other sustainable botanical sources, serving both the healthcare and beauty industries. Conversely, the Cosmeceutical Industry segment concentrates on the creation and commercial release of anti-aging goods. These products, formulated from natural active components, are primarily distributed straight to consumers through the company's online portal and via a network of specialized natural product retailers. Established in 1997, Ceapro Inc.'s main corporate office is located in Edmonton, Canada.

IndustryBiotechnology
CountryCanada
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free